title: Significance of a false-positive trisomy 18 multiple-marker screening test.
abstract: OBJECTIVE
  To determine if a false-positive trisomy 18 multiple-marker screening test (all three analytes low: maternal serum alpha-fetoprotein [AFP] at most 0.75 multiples of the median [MoM], unconjugated estriol at most 0.60 MoM, and hCG at most 0.55 MoM) indicates increased risk for obstetric complications or is related to maternal weight.
  
  
  METHODS
  We accessed our genetic database to obtain multiple-marker screening test results, fetal karyotypes, and pregnancy outcomes from all patients with a normal multiple-marker screening test (n = 3900) and from all patients with a positive trisomy 18 screening test (n = 103) seen in the prenatal diagnosis clinic from 1992 to 1996. During this period, only maternal serum AFP was adjusted for maternal weight.
  
  
  RESULTS
  A positive trisomy 18 screen identified five of 12 trisomy 18 fetuses. Women with a false-positive trisomy 18 screen were heavier (175.6 +/- 43.8 lb versus 159.9 +/- 37.9 lb, P < .001) and younger (29.7 +/- 6.5 years versus 32.3 +/- 6.5 years, P < .001) than women with a normal multiple-marker screening test, but were not at increased risk for pregnancy complications. Weight-adjusting all three analytes reduced the false-positive trisomy 18 screen rate by 42% (from 1.9% to 1.1%) but did not change the trisomy 18 detection rate.
  
  
  CONCLUSIONS
  A false-positive trisomy 18 screening test does not indicate increased risk to develop pregnancy complications and may be related to inadequate correction for increased maternal weight.
authors.affiliation: Department of Obstetrics and Gynecology, University of Alabama at Birmingham, USA.
authors.forename: K D
authors.initials: KD
authors.lastname: Wenstrom
authors.forename: J
authors.initials: J
authors.lastname: Owen
authors.forename: C G
authors.initials: CG
authors.lastname: Brumfield
authors.forename: R O
authors.initials: RO
authors.lastname: Davis
authors.forename: M
authors.initials: M
authors.lastname: Dubard
authors.forename: T
authors.initials: T
authors.lastname: Garcia
mesh_terms: D000328:Adult; D015982:Bias; D016022:Case-Control Studies; D006063:Chorionic Gonadotropin / Q000097:blood*; D002887:Chromosomes, Human, Pair 18; D004964:Estriol / Q000097:blood*; D005189:False Positive Reactions; D005260:Female; D005819:Genetic Markers / Q000235:genetics*; D005820:Genetic Testing / Q000592:standards*; D005865:Gestational Age; D006801:Humans; D011247:Pregnancy; D011256:Pregnancy Outcome; D012680:Sensitivity and Specificity; D014314:Trisomy / Q000235:genetics*; D000509:alpha-Fetoproteins / Q000032:analysis*
chemical_list: D006063:Chorionic Gonadotropin; D005819:Genetic Markers; D000509:alpha-Fetoproteins; D004964:Estriol